Promisia Integrative Limited (PIL)

[Balance]

Totally agree that all drugs give cause for concern if overdosed - that's partly how a dose is defined the difference between this product and a therapeutic drug is that a drug manufacturer is required to know exactly what is in their product and how much of it there is, so that a dose can be defined. Did you follow my point about why this is a problem for Arthrem?

I'm happy to take your word that the company gets their particular plants from a supplier in Tanzania and I don't dispute it. My point was that they likely have very little insight or power when it comes to growing conditions and quality control, as this crop is almost exclusively grown in developing nations far from NZ. Regarding India in particular: a massive expansion of Artemisia annua cultivation in India was partly responsible for crashing the price of artemisinin a couple of years ago (artemisinin = the approved antimalarial *pharmaceutical drug* that is *purified* from Artemisia annua extracts)

https://www.nzdoctor.co.nz/article/n...-harmful-liver

Biggest problem for PIL now is the potential liability it has overseas - could run into many millions of dollars if they get sued overseas.

They do not take prisoners overseas - unlike NZ.